First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050

Clinical trial NCT00607906 · COMPLETED

Trial details

NCT number: NCT00607906
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2007-11-16
Primary completion: 2008-03-10
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.